{"database": "lobbying", "table": "lobbying_activities", "rows": [[2954108, "4e95d65d-1534-428a-ab9f-9bfbf02629c3", "1T", "TIBER CREEK GROUP", 20744, "MCDERMOTT WILL & EMERY LLP (OBO ALNYLAM PHARMACEUTICALS)", 2023, "first_quarter", "MMM", "Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169).", "HOUSE OF REPRESENTATIVES,SENATE", 0, 1, "2023-03-10T09:42:48-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2954108"], "units": {}, "query_ms": 0.40897700819186866, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}